Chlamydia beyond the genital tract: a major contributor to community-acquired pneumonia
Abstract
Chlamydial pneumonia is a respiratory infection caused by three distinct species of obligate intracellular pathogens that include Chlamydia pneumoniae, C. psittaci, and C. trachomatis. Although they differ morphologically and are transmitted by distinct routes, all three organisms can elicit a complex clinical spectrum that ranges from acute pneumonia to chronic inflammation and extrapulmonary disease. Globally, chlamydial pneumonia represents a significant proportion of community-acquired pneumonia (CAP) cases, with species-specific prevalence varying by population and diagnostic method. However, diagnosis can be challenging due to the non-specific nature of its clinical presentation. Although serological testing is available for laboratory diagnosis, empirical antibiotic therapy based on clinical assessment is often sufficient for cure. The clinical course is generally mild, and the disease responds well to appropriate antibiotic treatment. This review summarizes the etiology, epidemiology, pathogenesis, and clinical manifestations of chlamydial pneumonia. We critically evaluate current diagnostic and therapeutic approaches, and discuss the associated public health burden. By synthesizing the latest evidence across these domains, this analysis aims to advance scientific understanding and provide a robust foundation for optimizing prevention, diagnostic accuracy, and therapeutic strategies against these complex infections.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.